NCT07611084Recruiting
Construction of a Cohort of Elderly Patients With Atrial Fibrillation in Rural China
Source: ClinicalTrials.gov · Last updated 28 May 2026
Brief summary (registry, in English)
Atrial fibrillation (AF) is a common arrhythmia in aging populations and is strongly associated with an increased risk of heart failure (HF) and adverse cardiovascular outcomes. However, early detection of HF among patients with AF remain inadequate in rural settings. This study aims to screen for HF among older adults with AF in rural China and to conduct long-term follow-up in order to observe the disease progression in patients with AF. This study will recruit at least 2,500 elderly individuals aged between 65 and 80 years, with confirmed diagnoses of AF, residing in rural areas. Participants will undergo HF screening using NT-proBNP testing and echocardiographic assessment. Additionally, data will be collected on electrocardiographic signals, seismocardiography, voice, and demographic characteristics. Following data collection, participants will be followed up every three months to monitor the incidence and progression of HF as well as the occurrence of adverse cardiovascular events.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 2500 (estimated)
- First submitted
- 18 May 2026
- Start date
- Mar 2026
- Primary completion date
- Dec 2029
- Lead sponsor
- Jiangsu Taizhou People's Hospital
- Diseases
- Heart failure, Atrial fibrillation
- NCT number
- NCT07611084
What you commit to
- Study type: Observational
- Planned participants: 2500
- From Mar 2026 to the primary completion date, Dec 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Severe renal insufficiency (Ccr \< 30ml/min) or ongoing dialysis treatment.
- Cardiac insufficiency secondary to correctable causes, including hyperthyroid heart disease, anemic heart disease, or uncorrected congenital heart disease.
- Chronic obstructive pulmonary disease complicated by type II respiratory failure.
- Special populations, including patients with mental illnesses.
Other
- Expected life expectancy of less than 3 months.
- Indications for pacemaker implantation without having undergone implantation.
Who the study is looking for
- Permanent residents with local household registration in rural China.
- Aged 65-80 years.
- Electrocardiogram confirmation of AF or possession of a diagnostic certificate for AF issued by a specialist.
- Willing to participate in HF screening.
- Ability to understand the study procedures and provide written informed consent.
Age in the registry: 65 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Cardiology Coordinator of this site? Confirm its status | Taizhou | China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.